Rock Inhibitor Treatment
Rock Inhibitor Treatment - Related Videos
04:00
Modelling Intratumoral Treatment with miRNA Inhibitors: A Method to Analyze the Effect of miRNA Inhibitors on Tumor Growth in Murine Model
0 Views •
2023
This video demonstrates the in vivo delivery of miRNA inhibitors as therapeutic agents against tumor growth in orthotopic mouse models. The intratumoral administration of synthetic miRNA inhibitors or antagomiRs allows them to bind and inhibit endogenous miRNAs, thereby causing mRNA upregulation and suppression of tumor growth.
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
0 Views •
Cited by 6 •
2013
Receptor tyrosine kinases are ectopically expressed in many cancers and have been identified as therapeutic targets in acute leukemia. This manuscript describes an efficient strategy for pre-clinical evaluation of tyrosine kinase inhibitors for the treatment of acute leukemia.
09:26
Igneous Intrusive Rock
0 Views •
2023
Source: Laboratory of Alan Lester - University of Colorado Boulder Igneous rocks are products of the cooling and crystallization of high temperature liquid rock, called magma. Magmatic temperatures typically range from approximately 800 °C to 1,200 °C. Molten rock is, perhaps luckily for humans, an anomaly on planet Earth. If a random and imaginary drill hole were made in the Earth, it would most likely not reach a region of truly and totally molten material until the outer core, at nearly...
07:28
Igneous Volcanic Rock
0 Views •
2023
Source: Laboratory of Alan Lester - University of Colorado Boulder Igneous rocks are the products of cooling and crystallization of magma. Volcanic rocks are a particular variety of igneous rock, forming as a consequence of magma breaching the surface, then cooling and crystallizing in the subaerial environment. Magma is molten rock that typically ranges in temperature from approximately 800 °C to 1,200 °C (Figure 1). Magma itself is produced within the Earth via three primary melting...
01:28
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
0 Views •
2024
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH). Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
FAQs
Blocking ROCK-dependent phosphorylation reduces actomyosin tension, the contractile force generated by actin and myosin. This relaxation can change cell shape, attachment, migration, and survival because these behaviors depend on cytoskeletal organization and adhesion. The treatment therefore provides a way to connect Rho-ROCK signaling with observable changes in cell behavior.
ROCK1 and ROCK2 are the kinase targets highlighted in this treatment. Their activity regulates phosphorylation of cytoskeletal targets, which helps control actin organization and cellular contractility. Considering both isoforms is important when interpreting an experiment, because the observed response reflects inhibition of ROCK-dependent signaling rather than a direct change to one isolated structural component.
Reduced contractile stress is especially relevant after cell dissociation, when cells must recover from being separated before they can attach and expand. ROCK inhibitor treatment can support this recovery by relaxing actomyosin tension and limiting stress linked to cytoskeletal remodeling. In practice, this makes the treatment useful for improving post-dissociation recovery in culture workflows.
Use in a workflow depends on the biological task rather than on a single universal purpose. The treatment is commonly incorporated during cell dissociation, primary cell culture, and stem cell maintenance, where attachment, survival, recovery, or expansion are important outcomes. Its effects should be interpreted in relation to the specific outcome being measured.
In organoid and tissue engineering workflows, the treatment is relevant because limiting contractile stress can improve cell recovery and expansion. Those effects support the development of multicellular systems in which researchers examine tissue organization and remodeling. This makes ROCK inhibition useful both for constructing experimental tissues and for regenerative medicine studies.
By altering Rho-ROCK-dependent cytoskeletal signaling, the treatment creates an experimental way to examine morphogenesis, differentiation, and tissue remodeling. Researchers can relate changes in cell shape, adhesion, migration, or survival to the signaling pathway that regulates them. This connects molecular control of actin organization with larger-scale changes in developing or engineered tissues.